Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: Alnylam Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Fractyl Health Inc. June 11, 202590.7%
-
Alnylam Pharmaceuticals Inc. May 8, 202587.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 9, 2026 | Alnylam Pharmaceuticals Inc. | Open-market purchase | +1,910 | $156.82 | $299,526 |
| May 20, 2026 | Alnylam Pharmaceuticals Inc. | Grant or award | +838 | — | — |
| May 13, 2026 | Elevance Health Inc. | Grant or award | +563 | — | — |
| May 13, 2026 | Alnylam Pharmaceuticals Inc. | Option exercise | +11,250 | $70.20 | $789,750 |
| Mar 12, 2026 | Elevance Health Inc. | Open-market sale | −26 | $287.50 | $7,475 |
| Feb 2, 2026 | Elevance Health Inc. | Grant or award | +218 | — | — |
| May 8, 2025 | Alnylam Pharmaceuticals Inc. | Grant or award | +775 | — | — |
| Mar 13, 2025 | Fractyl Health Inc. | Open-market purchase | +8,550 | $1.17 | $10,004 |
| Mar 13, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +2,750 | $131.21 | $360,828 |
| Jun 25, 2024 | Alnylam Pharmaceuticals Inc. | Option exercise | +8,500 | $131.21 | $1,115,285 |
| Jun 25, 2024 | Alnylam Pharmaceuticals Inc. | Open-market sale | −8,500 | $240.00 | $2,040,000 |
| May 29, 2024 | Alnylam Pharmaceuticals Inc. | Option exercise | +30,000 | $66.83 | $2,004,900 |
| May 29, 2024 | Alnylam Pharmaceuticals Inc. | Open-market sale | −10,121 | $148.21 | $1,500,033 |
| May 29, 2024 | Alnylam Pharmaceuticals Inc. | Open-market sale | −11,516 | $148.93 | $1,715,078 |
| May 29, 2024 | Alnylam Pharmaceuticals Inc. | Open-market sale | −63 | $149.76 | $9,435 |
Questions about Amy W. Schulman
What boards is Amy W. Schulman on?
Amy W. Schulman sits on the boards of Alnylam Pharmaceuticals Inc., Elevance Health Inc. and Fractyl Health Inc.
How long has Amy W. Schulman served on boards?
Our records show at least 7 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.